Hillsborough County Federal Opioid Prescribing Investigation Lawyer

Federal investigations into opioid prescribing rarely announce themselves with a knock at the door. They begin quietly, with subpoenas to pharmacies, interviews with former employees, and requests for patient records that a physician or practice administrator may not even know are happening. By the time a target is aware that the Drug Enforcement Administration or the Department of Justice has been gathering evidence, months or years of investigative work may already be complete. For healthcare professionals in Hillsborough County facing this reality, the question is not whether to take the situation seriously. The question is whether the lawyer who answers their call understands how these cases are built and how they can be dismantled. Daniel J. Fernandez, a Hillsborough County federal opioid prescribing investigation lawyer with over 43 years of criminal defense and trial experience, handles these cases from the earliest stage of federal scrutiny through trial if necessary.

How Federal Opioid Prescribing Investigations Are Constructed in the Middle District of Florida

The Middle District of Florida, which encompasses Hillsborough County and the surrounding Tampa Bay region, has been an active jurisdiction for federal healthcare fraud and drug diversion prosecutions. Cases against physicians, nurse practitioners, pain clinics, and pharmacies have been brought by the U.S. Attorney’s Office operating out of the federal courthouse on North Florida Avenue in Tampa, often in coordination with the DEA’s Tampa Division, the Department of Health and Human Services Office of Inspector General, and the Florida Attorney General’s Medicaid Fraud Control Unit.

These investigations typically begin with data. The DEA and federal prosecutors have access to the Florida Prescription Drug Monitoring Program, which logs every controlled substance prescription filled in the state. When a prescriber’s patterns deviate from what federal investigators consider normal, including high volumes of opioid prescriptions, a patient population that travels long distances to receive them, or a concentration of particular drugs like oxycodone or hydrocodone without corresponding diagnoses, that data becomes the foundation of a case theory. Investigators then layer in physical surveillance, undercover visits to the practice, interviews with pharmacists who filled the prescriptions, and reviews of medical charts looking for documentation deficiencies.

What makes these investigations particularly consequential is that prosecutors are not required to prove that a prescriber intended harm. Under federal drug statutes, the government must show that prescriptions were issued outside the usual course of professional practice and without a legitimate medical purpose. That is a legal standard that turns on clinical judgment, medical necessity, and documentation, not on whether patients were hurt. A prescriber who believed their treatment decisions were appropriate can still face charges if federal experts characterize those decisions as falling outside accepted standards of care.

The Charges That Emerge and What They Carry

A federal opioid prescribing investigation in Hillsborough County can produce several categories of criminal charges depending on what the government believes it can prove. The most direct path is a charge under the Controlled Substances Act for unlawful distribution of a controlled substance by a registrant. Each prescription the government classifies as unlawful can theoretically be charged as a separate count, which is why indictments in these cases often run to dozens or hundreds of individual allegations.

Healthcare fraud counts under 18 U.S.C. 1347 are frequently added when insurance billing is involved, on the theory that billing Medicare, Medicaid, or private insurers for medical services associated with unlawful prescriptions constitutes fraud. Money laundering allegations can follow if prescription revenues were deposited and spent in ways the government characterizes as concealing criminal proceeds. Conspiracy charges allow the government to rope in office staff, co-prescribers, and anyone else alleged to have participated in the scheme, even if their individual role was limited.

The sentencing exposure in these cases is substantial. Federal drug distribution convictions carry mandatory minimum sentences, and the weight of the controlled substances involved, calculated using DEA conversion tables, drives the guidelines range upward quickly. A conviction that results in a patient death or serious bodily injury triggers an enhanced mandatory minimum that applies regardless of the defendant’s personal culpability for that outcome. Conviction also means automatic loss of DEA registration, loss of state medical licensure, exclusion from federal healthcare programs, and the practical end of a medical career that took decades to build.

Where Defense Actually Begins in Cases Like These

In a federal opioid prescribing case, the defense is constructed from the same raw material the government is using, the patient charts, the prescription data, the billing records, and the clinical documentation. The difference is in how that material is read and by whom. A thorough defense requires a forensic review of the medical records to identify where the prescriber’s documented reasoning supports legitimate medical purpose. It requires independent expert witnesses who can offer qualified opinions on the standard of care applicable to the specific patient population being treated, whether that involves chronic pain, addiction medicine, or palliative care.

The government’s expert in these cases is almost always a physician retained to characterize the prescribing as outside professional norms. That opinion is not binding and it is not unassailable. The defense expert can point to literature supporting the treatment decisions made, highlight the prescriber’s documented efforts to screen for diversion, and challenge the government’s statistical methodology for identifying anomalous prescribing patterns. Prescription drug monitoring data looks damning in isolation. It looks different when placed alongside documentation of failed conservative treatments, patient histories of severe pain conditions, and evidence that the prescriber was following published clinical guidelines.

Daniel J. Fernandez spent time as a prosecutor before building his defense practice in Tampa, which means he approaches federal investigations from the perspective of someone who understands how charging decisions get made and what kinds of weaknesses in a government case a well-prepared defense team can expose. His more than 500 trials to verdict over a 43-year career include federal cases, and he knows how the Sam M. Gibbons United States Courthouse in Tampa operates, how federal prosecutors in the Middle District build their narrative for juries, and what it takes to present a persuasive counter-narrative when the government comes armed with data and expert testimony.

Questions Physicians and Healthcare Providers Ask About These Investigations

I received a grand jury subpoena for patient records. Does that mean I am a target?

Not necessarily, but it means you are at minimum a person of interest. Subpoenas go to witnesses, subjects, and targets alike. What matters is how you respond and whether you have counsel involved from the start. Producing records without understanding the scope of the investigation can inadvertently provide the government with material that shapes the case against you.

DEA agents came to my office and asked to speak with me informally. Should I talk to them?

No. There is no such thing as a fully informal interview with federal agents investigating prescribing practices. Anything said can be used to support charges, and statements made during voluntary interviews are often characterized later in ways the speaker never intended. Contact an attorney before any voluntary conversation with DEA investigators.

Can my DEA registration be suspended before charges are even filed?

Yes. The DEA has authority to issue an immediate suspension order if it concludes that continued registration poses an imminent danger to public health or safety. This can happen at any point in an investigation and does not require a criminal indictment. An attorney can seek to challenge or negotiate the terms of that suspension while the underlying investigation continues.

If the government offers a plea agreement, does accepting it avoid prison?

Not automatically. Federal plea agreements in drug distribution cases often involve sentencing guidelines ranges that still carry significant prison time, and mandatory minimums may apply depending on the charges. Whether a plea agreement is favorable depends entirely on what the government is offering against what they can likely prove at trial. No decision that consequential should be made without a full evaluation of the evidence.

Can a civil settlement with HHS resolve the criminal case at the same time?

Sometimes, but not always. Civil resolution under the False Claims Act or through an OIG integrity agreement can resolve the civil and administrative exposure without resolving criminal liability. The two tracks run independently, and accepting a civil settlement does not provide immunity from prosecution unless the agreement expressly includes a criminal release, which is relatively uncommon.

What happens to my medical license if I am indicted on federal drug charges?

A federal indictment typically triggers an automatic review by the Florida Department of Health. Depending on the charges and the Florida Board of Medicine’s emergency suspension authority, a license can be suspended before any conviction. Criminal defense counsel and a Florida administrative law attorney should be coordinating from the moment an indictment is filed.

How long do federal opioid investigations typically take before charges are filed?

These investigations routinely run for two to three years or longer before an indictment. The government’s timeline is not the target’s timeline, and the investigation may proceed through multiple grand jury sessions, expert witness preparation, and interagency coordination before prosecutors decide they have a sufficient case. Early retention of defense counsel gives the defense the same head start the government has been building.

Talk to Daniel J. Fernandez About a Federal Opioid Prescribing Defense in Hillsborough County

Federal opioid prescribing defense requires a lawyer who understands both the clinical standards at issue and the mechanics of federal prosecution in the Middle District of Florida. At Daniel J. Fernandez P.A., located steps from the Hillsborough County Courthouse in downtown Tampa, this firm has spent more than four decades building the kind of courtroom experience that federal cases demand. If you are a physician, nurse practitioner, pharmacist, or clinic administrator who has received a subpoena, an investigative inquiry, or notice of a DEA action in connection with a Hillsborough County federal opioid prescribing investigation, contact this office. The earlier defense counsel is involved, the more options remain available.